REmote iSchemic condItioning in Lymphoma Patients Receiving ANthraCyclinEs. RESILIENCE randomized clinical trial
CLINICAL RESEARCH WITH PROD. SANIT.
Clinical trial information
- Sponsor: CARLOS III NATIONAL CARDIOVASCULAR RESEARCH CENTER
- Execution start: 27/12/2022
- End of execution: 30/11/2026
- IP: JOSE M PUERTA PUERTA
